NEW YORK, Jan 25 –- Celera said Thursday its second quarter fiscal 2001revenues surged to $20.3 million from $8.3 million in the year-ago period as the company continued to rack up one new commercial and three new academic subscribers.
Already have a GenomeWeb or 360Dx account?Login Now.
360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.
The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.
In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.
Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.